Zydus Lifesciences Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
18
Price Target
Rp840.00
Consensus
Outperform
Downside
-15.53%
Analysts
22
Stock Rating
18
Downside
-15.53%
Analysts
22
Price Target
Rp840.00

Zydus Lifesciences Stock Forecast and Price Target

In recent months, Twenty two notable analysts have provided yearlong price targets for Zydus Lifesciences, with the average target coming in at Rp840.00. If it were to be achieved, this would result in a potential downside of approximately -15.53 percent from the most recent closing price in March, 2024. The high end is Rp1107.00, and the low is Rp550.00. If interested in ZYDUSLIFE stock, you may also want to consider its competitors.

Rp840.00

-15.53% Downside

Outperform
Outperform

Zydus Lifesciences Fair Value Forecast for 2023 - 2025 - 2030

Zydus Lifesciences's Price has grown in the last three years, jumping from Rp278.46 to Rp466.83 – an increase of 67.65%. In the next year, analysts predict that Fair Value will reach Rp596.12 – an increase of 27.69%. For the next seven years, the forecast is for Fair Value to grow by 36.38%.

2024 Fair Value Forecast
Rp596.12
2025 Fair Value Forecast
Rp630.63
2026 Fair Value Forecast
Rp668.66
2027 Fair Value Forecast
Rp622.05
2028 Fair Value Forecast
Rp614.44
2029 Fair Value Forecast
Rp620.67
2030 Fair Value Forecast
Rp636.66
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$734.37 Buy/Sell $636.99 10.71%
MRK Stock Forecast Merck Outperform 2
$122.77 Buy/Sell $130.51 9.96%
ABT Stock Forecast Abbott Laboratories Outperform 9
$120.19 Buy/Sell $118.92 4.83%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
SAN Stock Forecast Sanofi Outperform 16
88.32€ Buy/Sell 102.80€ 21.15%

Zydus Lifesciences Revenue Forecast for 2023 - 2025 - 2030

Zydus Lifesciences's Revenue has grown in the last three years, jumping from Rp142.53B to Rp172.37B – an increase of 20.94%. In the next year, analysts predict that Revenue will reach Rp191.10B – an increase of 10.86%. For the next seven years, the forecast is for Revenue to grow by 26.76%.

2024 Rev Forecast
Rp191.10B
2025 Rev Forecast
Rp207.71B
2026 Rev Forecast
Rp222.93B
2027 Rev Forecast
Rp235.27B
2028 Rev Forecast
Rp219.52B
2029 Rev Forecast
Rp215.93B
2030 Rev Forecast
Rp218.51B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GSK Stock Forecast GSK Outperform 12
£16.75 Buy/Sell £17.30 11.04%
ZTS Stock Forecast Zoetis Outperform 18
$183.49 Buy/Sell $220.47 20.72%
SUNPHARMA Stock Forecast Sun Pharmaceutical Industries Outperform 8
Rp1.59k Buy/Sell Rp1.52k -1.42%

Zydus Lifesciences Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Zydus Lifesciences's Dividend per Share has increased by 71.43%, going from Rp3.50 to Rp6.00. According to 23 major analysts, Zydus Lifesciences's Dividend per Share will fall by 12.50% in the next year, reaching Rp5.25. Professionals believe that By 2030, Zydus Lifesciences's Dividend per Share will fall to Rp5.79– a 3.48% decrease from its current value.

2024 DPS Forecast
Rp5.25
2025 DPS Forecast
Rp5.65
2026 DPS Forecast
Rp5.95
2027 DPS Forecast
Rp5.99
2028 DPS Forecast
Rp5.74
2029 DPS Forecast
Rp5.71
2030 DPS Forecast
Rp5.79
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAYN Stock Forecast Bayer Hold 5
26.82€ Buy/Sell 45.15€ 26.77%
TEVA Stock Forecast Teva Pharmaceutical Industries Outperform 12
$13.35 Buy/Sell $11.59 19.85%
CIPLA Stock Forecast Cipla Outperform 18
Rp1.50k Buy/Sell Rp1.43k -1.93%

Zydus Lifesciences Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
Rp27.08B
2025 FCF Forecast
Rp27.17B
2026 FCF Forecast
Rp30.01B
2027 FCF Forecast
Rp23.60B
2028 FCF Forecast
Rp24.96B
2029 FCF Forecast
Rp25.98B
2030 FCF Forecast
Rp27.52B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VTRS Stock Forecast Viatris Inc Hold 8
$11.97 Buy/Sell $11.73 0.25%
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp6.38k Buy/Sell Rp5.67k -6.20%
500420 Stock Forecast Torrent Pharmaceuticals Outperform 18
Rp2.70k Buy/Sell Rp2.13k 3.82%

Zydus Lifesciences EBITDA Forecast for 2023 - 2025 - 2030

Zydus Lifesciences's EBITDA has increased by 28.05% In the last three years, going from Rp27.60B to Rp35.34B. In the next year, analysts expect EBITDA to reach Rp46.91B – an increase of 32.73%. For the next seven years, the forecast is for EBITDA to grow by 42.20%.

2024 EBITDA Forecast
Rp46.91B
2025 EBITDA Forecast
Rp49.78B
2026 EBITDA Forecast
Rp52.45B
2027 EBITDA Forecast
Rp49.68B
2028 EBITDA Forecast
Rp48.81B
2029 EBITDA Forecast
Rp49.18B
2030 EBITDA Forecast
Rp50.26B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
APOLLOHOSP Stock Forecast Apollo Hospitals Enterprise Outperform 18
Rp6.20k Buy/Sell Rp6.91k 15.89%
500257 Stock Forecast Lupin Hold 12
Rp1.67k Buy/Sell Rp1.11k -8.05%
ELAN Stock Forecast Elanco Animal Health Outperform 13
$16.02 Buy/Sell $14.90 12.36%

Zydus Lifesciences EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Zydus Lifesciences's EBIT has grown, increasing from Rp21.02B to Rp28.53B – a growth of 35.74%. The next year looks promising for Zydus Lifesciences, with analysts predicting EBIT of Rp39.88B – an increase of 39.79%. Over the next seven years, experts anticipate that Zydus Lifesciences's EBIT will grow at a rate of 46.73%.

2024 EBIT Forecast
Rp39.88B
2025 EBIT Forecast
Rp42.20B
2026 EBIT Forecast
Rp43.70B
2027 EBIT Forecast
Rp40.25B
2028 EBIT Forecast
Rp40.20B
2029 EBIT Forecast
Rp40.91B
2030 EBIT Forecast
Rp41.86B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
500488 Stock Forecast Abbott India Outperform 18
Rp27.23k Buy/Sell Rp24.75k 5.19%
AUROPHARMA Stock Forecast Aurobindo Pharma Outperform 18
Rp1.06k Buy/Sell Rp1.09k 10.08%
HIK Stock Forecast Hikma Pharmaceuticals PLC Outperform 18
£19.10 Buy/Sell £28.11 55.34%

Zydus Lifesciences EPS Price Prediction Forecast for 2023 - 2025 - 2030

Zydus Lifesciences's EPS has grown in the last three years, jumping from Rp14.28 to Rp23.94 – an increase of 67.65%. In the next year, analysts predict that EPS will reach Rp30.57 – an increase of 27.69%. For the next seven years, the forecast is for EPS to grow by 36.38%.

2024 EPS Forecast
Rp30.57
2025 EPS Forecast
Rp32.34
2026 EPS Forecast
Rp34.29
2027 EPS Forecast
Rp31.90
2028 EPS Forecast
Rp31.51
2029 EPS Forecast
Rp31.83
2030 EPS Forecast
Rp32.65
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
500660 Stock Forecast GlaxoSmithKline Pharmaceutical... Hold 18
Rp2.01k Buy/Sell Rp1.78k 5.21%
BIOCON Stock Forecast Biocon Hold 14
Rp279.20 Buy/Sell Rp270.86 2.08%
VIRP Stock Forecast Virbac Outperform 18
342.00€ Buy/Sell 347.01€ 2.05%